Hearing Impaired
8
1
1
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (8)
A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound
Brain and Cognitive Changes After Reasoning or Physical Training in Cognitively Normal Seniors
RBANS-H in Older Patients Before and After Cochlear Implantation: A Protocol for a Prospective Study
Educational Program for Hearing Aid Users With Internet Support
Cochlear Implant PDA Based Research Platform
Functioning, Disability, and Quality of Life in the Adult Hearing Impaired
Effects of Stimulus Validity on Speech Recognition
Measurement and Prediction of Outcomes of Amplification